Spots Global Cancer Trial Database for apatinib mesylate tablets
Every month we try and update this database with for apatinib mesylate tablets cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer | NCT03219593 | Gastric Cancer Apatinib Biomarker | Apatinib mesyla... | 65 Years - | First Affiliated Hospital Bengbu Medical College | |
| A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | NCT04714190 | Gastric Cancer HER2 Overexpres... | RC48-ADC Paclitaxel inje... Irinotecan Hydr... Apatinib Mesyla... | 18 Years - | RemeGen Co., Ltd. | |
| Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer | NCT03050411 | Nonsmall Cell L... | Apatinib Mesyla... EGFR-TKIs (Erlo... | 18 Years - 75 Years | Peking University Third Hospital | |
| A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy | NCT02776527 | Gastric Cancer | Apatinib Mesyla... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers | NCT03096184 | Head and Neck S... | Apatinib Mesyla... Tegafur Gimerac... | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Effect of Itraconazole on the Pharmacokinetics of Apatinib | NCT02836171 | Neoplasms | Apatinib Mesyla... Itraconazole Ca... | 18 Years - 45 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | NCT04714190 | Gastric Cancer HER2 Overexpres... | RC48-ADC Paclitaxel inje... Irinotecan Hydr... Apatinib Mesyla... | 18 Years - | RemeGen Co., Ltd. | |
| Effect of Rifampicin on the Pharmacokinetics of Apatinib | NCT02836821 | Neoplasms | Apatinib Mesyla... Rifampicin Caps... | 18 Years - 45 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C) | NCT03743428 | Colorectal Neop... | Apatinib Mesyla... Bevacizumab Inj... | 18 Years - 75 Years | Shenzhen People's Hospital | |
| A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure | NCT02772029 | Hepatocellular ... | Apatinib Mesyla... | 18 Years - 75 Years | The First Affiliated Hospital of Zhengzhou University | |
| Effect of Itraconazole on the Pharmacokinetics of Apatinib | NCT02836171 | Neoplasms | Apatinib Mesyla... Itraconazole Ca... | 18 Years - 45 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure | NCT02772029 | Hepatocellular ... | Apatinib Mesyla... | 18 Years - 75 Years | The First Affiliated Hospital of Zhengzhou University | |
| Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children | NCT03868852 | Childhood Rhabd... | Apatinib mesyla... Three-dimension... | 3 Years - 18 Years | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
| A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure | NCT02772029 | Hepatocellular ... | Apatinib Mesyla... | 18 Years - 75 Years | The First Affiliated Hospital of Zhengzhou University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
